Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paraneoplastic syndromes in prostate cancer.
Hong MK, Kong J, Namdarian B, Longano A, Grummet J, Hovens CM, Costello AJ, Corcoran NM. Hong MK, et al. Among authors: grummet j. Nat Rev Urol. 2010 Dec;7(12):681-92. doi: 10.1038/nrurol.2010.186. Nat Rev Urol. 2010. PMID: 21139643 Review.
Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.
Satasivam P, Reeves F, Rao K, Ivey Z, Basto M, Yip M, Roth H, Grummet J, Goad J, Moon D, Murphy D, Appu S, Lawrentschuk N, Bolton D, Kearsley J, Costello A, Frydenberg M. Satasivam P, et al. Among authors: grummet j. BJU Int. 2015 Oct;116(4):590-5. doi: 10.1111/bju.13075. Epub 2015 Mar 30. BJU Int. 2015. PMID: 25676543
Prostate Cancer Management in an Ageing Population.
Grummet JP, Plass K, N'Dow J. Grummet JP, et al. Eur Urol. 2017 Oct;72(4):532-533. doi: 10.1016/j.eururo.2017.04.010. Epub 2017 Apr 19. Eur Urol. 2017. PMID: 28433378 No abstract available.
Editorial Comment.
Grummet J. Grummet J. J Urol. 2019 Feb;201(2):276. doi: 10.1097/01.JU.0000553012.34584.f6. J Urol. 2019. PMID: 30634355 No abstract available.
Editorial Comment.
Grummet J. Grummet J. J Urol. 2019 Jun;201(6):1126. doi: 10.1097/01.JU.0000554642.01683.af. J Urol. 2019. PMID: 30864925 No abstract available.
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial.
Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D, Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters JS, So K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C. Bowden P, et al. Among authors: grummet j. Int J Cancer. 2020 Jan 1;146(1):161-168. doi: 10.1002/ijc.32509. Epub 2019 Jun 28. Int J Cancer. 2020. PMID: 31199504 Free article. Clinical Trial.
86 results